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ABSTRACT
Background. Malignant obstruction of the proximal colon
(MOPC) traditionally has been treated with acute resec-
tion. However, morbidity and mortality rates following
these emergency surgeries are high. Initial bowel decom-
pression by stent placement or stoma construction has been
used for distal obstructions as an alternative approach. This
study evaluated whether these alternative treatment
strategies could be beneficial for patients with a MOPC as
well.
Methods. All patients undergoing a colonic resection for a
MOPC between January 2009 and December 2013 and
who were registered in the Dutch Surgical Colorectal Audit
were analyzed.
Results. From the 49,013 patients registered in the DSCA,
1860 (3.8 %) were selected for further analysis. Acute
resection was performed in 1774 patients (95.4 %), 44
patients (2.4 %) were treated with initial decompression
using stent placement and resection, and 42 patients
(2.3 %) with stoma construction followed by resec-
tion. Thirty-day mortality was 8.8, 2.4, and 2.4 %,
respectively. Mortality was significantly lower after a
bridging strategy (stent or stoma) compared with acute
resection (p = 0.04). Complications following the resec-
tion occurred in 39.6% in the acute resection group and in
27.3 and 31.7% in the stent and stoma group, respectively
(p = 0.167).
Conclusions. Acute resection was performed in the vast
majority of patients with obstructive proximal colon cancer
and resulted in a 40 % morbidity and 9 % mortality rate. A
bridging strategy may be a valid alternative in some of
these patients, because a significantly lower postoperative
mortality rate was seen in a subgroup of patients initially
treated with a stent or stoma.
Colon carcinoma is one of the most frequently
encountered malignancies in the western world, and each
year its incidence increases.1 Up to 9–13 % of all patients
with colon cancer present with acute bowel obstruction.2–4
Approximately 33–54 % of these obstructing tumors are
located in the proximal colon.5–7
Malignant obstruction of the proximal colon (MOPC) is
considered a life-threatening condition that requires
emergency surgery. Traditionally, MOPC has been treated
with acute resection and primary anastomosis, which was
deemed safe after several prospective studies showed no
difference in mortality or morbidity rates when emergency
and elective resections were compared.8 Recent studies,
however, have shown significantly higher mortality rates in
up to 34 % of patients after emergency resections.9–11
Patients presenting with MOPC often are elderly and in
poor physical condition due to several days of reduced
intake, vomiting, and weight loss before presentation.
These factors are associated with an increased operative
risk leading to high mortality rates.9,11,12 Initial colonic
decompression using a minimally invasive procedure as a
bridge to surgery (BTS) might be an attractive alternative
to acute resection. This approach creates time to optimize
the patients’ condition and perform oncologic staging,
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which could prevent unnecessary surgery in palliative
patients. A BTS approach can be achieved by endoscopic
stent placement at the site of obstruction or by stoma
construction proximal to the obstruction.
The BTS approach has been extensively researched for
left-sided colonic obstructions. In the recently published
European Guideline on colonic stenting, BTS by stent
placement in the curative setting is recommended for all
patients C70 years or with an ASA-score C3.13 However,
\5 % of all literature on colonic obstruction involves
stenting in the proximal colon and, to our knowledge, no
literature is available on stoma as BTS for MOPC at all.14
A recent systematic review comparing stent and acute
resection for MOPC suggested lower mortality and mor-
bidity rates when stent placement is used as BTS, but the
included studies were small and of low quality.15
This study was designed to determine the use and cor-
responding outcomes of a BTS approach using stent
placement or stoma creation in the Netherlands from 2009–
2013, based on prospectively registered data. In addition,
the outcomes of both BTS strategies were compared to the
outcomes following emergency resection.
PATIENTS AND METHODS
Study Design and Population
Data of all patients who underwent a resection for
MOPC between 2009-2013 were collected from a
prospective national colorectal cancer registry: the dutch
surgical colorectal audit (DSCA). This registry includes
data for all patients undergoing resection of colorectal
cancer in the Netherlands. All Dutch hospitals are obliged
to deliver these data, and validity is achieved by control
tools in the web-based data entry program, by sending
feedback on missing or improbable data, and by annual
comparison with the National Cancer Registry on com-
pleteness and accuracy.16 The database was obtained after
approval of the study protocol by the DSCA review board.
Patients were included for analysis when they met the
following criteria: (1) symptomatic colonic obstruction, (2)
proximal location of the obstruction (cecum, ascending
colon, hepatic flexure or transverse colon), and (3) the
obstruction was caused by histologically proven colon
cancer. After patient selection from the DSCA database,
patients were further subdivided into three groups
depending on the initial treatment strategy applied: stent
placement, stoma construction, or acute resection. When
initial decompression using stent placement had failed and
emergency surgery was performed, the patient was still
analyzed as having undergone stent placement. Patients
presenting with perforation and fecal peritonitis were
excluded from analyses.
Data Extraction
The following data were extracted from the DSCA
database: patient characteristics (age, gender, ASA score),
surgical characteristics (urgency of surgery, resection type,
open/laparoscopic approach, type of BTS approach used),
data on the primary tumor (pathological TNM-stage,
location), overall complication rate, and mortality. Mor-
tality was defined as death within 30 days or during
hospital stay after resection. Overall complications were
defined as surgical and nonsurgical complications occur-
ring within 30 days or in-hospital. No long-term data or
data on complications associated with an initial decom-
pression are registered in the DSCA. Furthermore, data on
decision-making regarding treatment approaches is not
available, although we know that mainly one regional
teaching hospital performed stent as BTS during the study
period. Because all data in the DSCA database are
anonymous, retrieval of missing data was not possible.
Outcome Parameters
Patients treated with stent placement, stoma construc-
tion, or acute resection were compared for baseline
characteristics and outcome parameters. The primary out-
come measure was mortality. Other outcome parameters
were overall complication rate and the percentage of rad-
ical resections.
Statistical Analysis
Statistical analysis was performed using SPSS statistics
22. Continues variables were described as mean with
standard deviation and range. Categorical variables were
described as counts and percentages. Fisher’s exact test or
the v2 test was used for data analysis with categorical
variables and one-way ANOVA for analysis of continues
variables. Reported p values are two-sided and were con-
sidered significant when\0.05.
RESULTS
Patient’s Characteristics
Between January 2009 and December 2013, a total of
49,014 patients were included in the DSCA database; 1860
patients had MOPC and were eligible for the present
analysis. Overall, 1774 (95.4 %) patients were treated with
acute resection, 44 (2.4 %) patients received a stent and
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subsequent resection, and 42 (2.3 %) patients had a stoma
created as a BTS (Fig. 1). A decrease in the frequency of
stent placement was observed from approximately 3.5 % in
2009–2012 to 0.5 % in 2012–2013.
ASA score and gender were similar between treatment
groups (Table 1). The stoma group had a significantly
lower age (64.9 years) compared with the stent and acute
resection groups (69.9 and 71.4 years, respectively,
p = 0.001). In addition, more tumors were localized in the
transverse colon and fewer in the ascending colon in
patients treated with stent compared with stoma or acute
resection (p\ 0.001). Significantly more patients had a
pT4 stage in the stoma group, whereas M1 stage was
similar among treatment groups.
Surgical Characteristics
After stent placement or stoma construction, resection
was performed in an elective setting in 79.5 and 90.5% of
the patients, respectively (Table 2). An emergency resec-
tion (\12 h) was performed in four patients of the stent
group and in none of the stoma group. Reasons for emer-
gency surgery, despite (an attempt to) colonic
decompression, are not registered in the DSCA. However,
two patients in the stent group had a registered perforation
with fecal peritonitis as a possible explanation of the four
emergency resections. Urgent resection (not according to
elective planning) was performed in five and four patients
of the stent and stoma groups, respectively.
The interval between the initial colonic decompression
and eventual (elective) resection differed significantly
between stent placement and stoma creation (28.1 vs.
109.9 days, p = 0.01). More transversectomies and left
hemicolectomies were performed in the BTS groups
compared with the acute resection group, which was rela-
ted to differences in tumor localization. Furthermore, a
laparoscopic approach was significantly more frequently
used after stent placement when compared to stoma con-
struction and acute resection (22.7 vs. 9.5 vs. 8.5 %,
respectively, p = 0.027). No differences were found in the
total number of primary constructed anastomoses, number
of protective stomas after resection, or the use of postop-
erative chemotherapy.
Outcome Parameters
Mortality in the stent, stoma, and acute resection groups
was 2.4, 2.4, and 8.8 %, respectively. When stent and
stoma patients were analyzed together as BTS group and
compared with acute resection, the difference in mortality
was statistically significant (p = 0.04). Mortality rates for
different subgroups based on age, ASA score, and type of
resection for patients who underwent acute resection are
shown in Table 3. Subgroup analyses could not be per-
formed for the stent and stoma groups due to the low
number of events.
The number of complications within 30 days after
resection was equal between treatment groups. However, if
DSCA registry
N = 49.013
Excluded:
Carcinoma’s distal of splenic flexure
N = 32.059
Excluded:
No obstruction
N = 15.094
Proximal Colon
N = 16.954
MOPC
N = 1860 (100%)
Stent placement
followed by resection
N = 44 (2.4%)
Stoma followed by 
resection
N = 42 (2.3%)
Acute resection
N = 1774 (94.4%)
FIG. 1 Patient selection from the DSCA database from 2009–2013. DCSA dutch surgical colorectal audit, MOPC malignant obstruction of the
proximal colon
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stent placement was compared separately to acute resec-
tion, a borderline significant difference in favor of stent
was found (27.3 vs. 39.6 %, p = 0.051) (Table 3). Rein-
tervention rate was not significantly different between the
treatment groups; in addition, the type of complication
requiring reintervention did not differ. Postoperative
complication rate for both the stent and stoma groups were
lower when initial decompression was clinically successful
and followed by elective resection. When acute resection
was compared with only those patients in whom
TABLE 3 Surgical outcomes
N = 1860 Stent followed
by resection n
(%) N = 44
Stoma followed
by resection
(%) N = 42
Acute
resection
(%)
N = 1774
p value stent
versus stoma
versus acute
resection
p value stent/
stoma versus
acute resection
p value stent
versus acute
resection
p value stoma
versus acute
resection
Complications within
30 days (N = 1850)
12/44 (27.3) 13/41 (31.7) 699/1765
(39.6)
0.17 0.07 0.05 0.22
Reintervention
(N = 1082)
8/28 (28.6) 10/29 (34.5) 240/1025
(23.4)
0.32 0.20 0.63 0.18
Reintervention indication 0.92 0.89 0.95 0.57
Anastomotic leakage 2 (22.2) 5 (50.0) 111 (42.5) 0.42 0.63 0.32 0.63
Abscess 1 (11.1) 1 (10.0) 29 (11.1) 0.99 0.94 0.90 0.92
Re-bleeding 1 (11.1) 0 (0.0) 16 (6.1) 0.59 0.88 0.46 0.42
Ileus 1 (11.1) 0 (0.0) 15 (15.7) 0.58 0.93 0.42 0.44
Fascia dehiscence 2 (22.2) 4 (40.0) 41 (15.7) 0.12 0.07 0.47 0.04
Other 0 (0.0) 0 (0.0) 2 (0.8) 0.30 0.37 0.64 0.13
Type of reintervention (N = 262)
Radiological 1 (12.5) 1 (10.0) 26 (6.2) 0.91 0.67 0.55 0.82
Laparoscopy 1 (12.5) 1 (10.0) 2 (1.6) \0.01 \0.01 \0.01 \0.01
Laparotomy 4 (50.0) 5 (50.0) 196 (81.6) 0.21 0.08 0.09 0.24
Other/unknown 2 (25.0) 3 (30.0) 16 (6.6) 0.08 0.03 0.05 0.12
Completeness of resection (N = 1738)
R0 37/40 (92.5) 33/39 (84.6) 1524/1659
(91.9)
0.26 0.30 0.97 0.13
R1 1/40 (2.5) 6/39 (15.4) 76/1659
(4.6)
\0.01 0.08 0.60 0.01
R2 2/40 (5.0) 0/39 (0.0) 58/1659
(3.5)
0.43 0.65 0.50 0.22
30-day mortality
(N = 1843)
1/42 (2.4) 1/42 (2.4) 155/1759
(8.8)
0.17 0.04 0.16 0.17
B70 years – – 36/815
(4.4)
[70 years – – 118/947
(12.5)a
ASA 1–2 – – 59/1186
(5.0)
ASA 3–5 – – 97/629
(15.4)b
Ileocecal resection/right
hemicolectomy
– – 125/1489
(8.4)
Transversectomy/left
hemicolectomy/subtotal
colectomy
– – 26/240
(10.8)c
a p value\70 versus 70 years:\0.01
b p value ASA 1–2 versus ASA 3–5:\0.01
c p value right-sided colonic resection versus left-sided colonic resection: 0.07
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decompression with stent or stoma before resection was
successful, complication rates did significantly differ
(39.7 % after acute resection, 27.0 % after stoma and
elective resection, and 22.9 % for stent and elective
resection, p = 0.043).
No significant difference was found between treatment
groups with regard to completeness of resection; however,
more microscopic irradical resections (R1) were seen in the
stoma group (15.4 %) compared with the stent (2.5 %) and
acute resection (4.6 %) groups.
DISCUSSION
This large, population-based analysis of MOPC
demonstrated that acute resection was performed in 95 %
of the patients, with a primary anastomosis rate of 86 %. A
decompressing intervention as BTS was performed in only
5 % of the patients. Mortality was significantly lower after
a bridging strategy compared with acute resection. In
addition, mortality rates after acute resection were
approximately three times higher in patients C70 years or
with an ASA-score C3.
These observations are clinically important, because
they may lead to a more patient-tailored treatment strategy.
Our findings suggest that mortality rates could have been
lower if more patients had been treated with a BTS,
especially elderly patients with one or more comorbidities.
Interestingly, a decrease in stent placement for MOPC from
3.5 % in 2009 to 0.5 % in 2013 was seen. This change in
decision-making is probably the result of the premature
closure of two Dutch randomized, controlled trials com-
paring stent with emergency surgery. Both trials were
prematurely closed due to the high incidence of stent-re-
lated complications, making physicians more hesitant
towards stent placement.17,18 Unfortunately, definitive
conclusions cannot be drawn solely based on the outcomes
of the present study, because this is an observational cohort
study with a risk of selection bias. It is not known from the
DSCA database how patients were selected for the differ-
ent treatment strategies. Ninety-two hospitals included
patients, and treatment approaches highly depended on
local expertise. Despite these methodological issues, the
present data represent the best available evidence, because
no randomized trials have been performed and the present
study is the largest comparative series available.
The current findings agree with observations for left-
sided colonic obstructions in the literature.19 It may be that
treatment strategies for MOPC and left-sided malignant
colonic obstruction should be identical. Nonetheless, the
recently published European guideline on colonic stenting
recommends a bridging strategy only for left-sided
obstructing colon cancer patients with an increased
operative risk (age C70 years/ASA-score C3).13 The pre-
sent data support such an approach for MOPC as well,
which could ultimately lower mortality rates, especially in
elderly and frail patients.
Several studies have tried to identify independent pre-
dictors of mortality when performing emergency surgery
for large-bowel obstruction. Tekkis et al. analyzed a group
of right- and left-sided colonic obstructions and found
significantly higher mortality for patients C70 years or
with an ASA-score C3.20 Kobayashi et al. evaluated a
cohort of 15,275 patients who underwent a right hemi-
colectomy and found an odds ratio of 2.32 in patients with
ASA scores C3.9 In addition, several other studies have
associated ASA score C3 and advanced age with higher
mortality after colorectal surgery; however, no studies have
specifically identified risk factors for MOPC.11,12,21
Studies on MOPC are scarce, and to our knowledge, no
other articles on decompressing stoma as BTS for MOPC
have been published. A recent systematic review compar-
ing stent as BTS with acute resection in MOPC patients
showed a mortality rate of 0% in the stent group versus
10.8% in the acute resection group (p = 0.009). In addi-
tion, stenting was associated with lower morbidity rates
and fewer permanent stomas. These retrospective results
are similar and supportive to those found is our prospective
analysis.15 However, these data should be interpreted with
caution, because all included studies in the systematic
review were cohort studies. Kye et al.22 recently published
the first study directly comparing stent and acute resection
as treatment options for MOPC. Similar to our outcomes,
they found laparoscopic resection rate to be significantly
higher following stent placement. In addition, significantly
more lymph nodes were harvested in the stent group.
Contrary to our study, however, they did not find a sig-
nificant difference in 30-day mortality and morbidity.22 A
possible explanation for this discrepancy could be that they
included considerable fewer patients than the current study
and might have lacked power to demonstrate a significant
difference.
Based on the currently available data, a bridging strat-
egy might be the preferred initial approach in elderly and/
or frail patients, where the risk of emergency surgery might
be relatively high. However, stent placement for left-sided
obstructing colon cancer has been used with reserve during
the past years, which is probably due to fear about stent-
related complications and uncertainty about the oncologic
long-term outcomes.23,24 Initially, based on retrospective
data, stent placement for left-sided obstructing colon can-
cer was thought to be a promising alternative to acute
resection. However, several prospective trials had to be
closed due to stent-related complications.17,25 The high
technical and clinical success rates in retrospective studies
might have been due to selection bias, where only patients
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with a subtotal, instead of a total occlusion were treated
with stent placement. It is important to realize that this also
could be the case for MOPC, because no prospective data
are available yet. In addition, the long distance from the
anus and the tortuosity of the bowel make proximal
stenting considerably more difficult than in the distal
colon.14,26,27 In line with this, higher technical failure rates
have been reported for proximal stenting, which is most
commonly caused by an inability to pass the guidewire
through an angulated colon, such as the hepatic flexure.27
The DSCA database has a high participation rate from
Dutch hospitals ([95%) and presents a good reflection of
general practice in surgery for colorectal cancer in the
Netherlands.1 A few limitations should be kept in mind.
DSCA data are registered anonymously, making it impos-
sible to retrieve missing values from the original patient
files. Furthermore, because only patients with a colorectal
resection are included in the DSCA database, patients in
whom a stent was placed but never underwent colonic
resection were excluded. Another limitation is that com-
plications and hospital stay related to initial decompression
are not available in the registry; this might have had a
positive influence on the overall outcomes in the BTS
treatment groups.
Keeping these considerations in mind, this study indi-
cates a possible advantage for stent or stoma as a BTS in
patients with MOPC compared with acute resection, and
high-risk patients potentially benefit most from such a
strategy. Our data suggest that the current recommendation
for stenting in left-sided colon cancer (ESGE guideline13)
can be extended to proximal obstructions. A decompress-
ing stoma can be considered an alternative in patients with
high operative risk if stenting is not technically feasible or
in locally advanced tumors. To optimize a patient-tailored
treatment strategy, future research should be focused on
identifying more predictors to enable better selection of
subgroups of patients who benefit most from a specific
treatment strategy.
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